These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22114020)

  • 1. Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement.
    Jung SC; Cho JY; Kim SH
    Acta Radiol; 2012 Feb; 53(1):112-8. PubMed ID: 22114020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Young JA; Hsu M; Raman SS
    Abdom Imaging; 2014 Jun; 39(3):543-9. PubMed ID: 24573763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
    AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT.
    Bata P; Gyebnar J; Tarnoki DL; Tarnoki AD; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
    Diagn Interv Radiol; 2013; 19(5):387-92. PubMed ID: 23864331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiomyolipoma with minimal fat and non-clear cell renal cell carcinoma: differentiation on MDCT using classification and regression tree analysis-based algorithm.
    Woo S; Cho JY; Kim SH; Kim SY
    Acta Radiol; 2014 Dec; 55(10):1258-69. PubMed ID: 24259298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound.
    Lu Q; Huang BJ; Xue LY; Fan PL; Wang WP
    AJR Am J Roentgenol; 2015 Sep; 205(3):W335-42. PubMed ID: 26295670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT.
    Young JR; Coy H; Douek M; Lo P; Sayre J; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1911-1918. PubMed ID: 28265706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
    Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
    Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differentiation of subtypes of renal cell carcinoma by double-phase helical computed tomography].
    Dai JR; Zhang LY; Zhang J; Chen Y; Zhang HT; Jiang LX; Lin M
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2177-81. PubMed ID: 21029656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas.
    Woo S; Cho JY; Kim SH; Kim SY
    AJR Am J Roentgenol; 2013 Sep; 201(3):598-604. PubMed ID: 23971452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.
    Egbert ND; Caoili EM; Cohan RH; Davenport MS; Francis IR; Kunju LP; Ellis JH
    AJR Am J Roentgenol; 2013 Aug; 201(2):347-55. PubMed ID: 23883215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma: radiology-pathology correlation.
    Halefoglu AM; Ozagari AA
    Pol J Radiol; 2021; 86():e583-e593. PubMed ID: 34876939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.